Amir Lahav ScD

Dr Amir Lahav is a clinical neuroscientist and a leading innovator in digital health with a special focus on developing and validating novel biomarkers and AI-driven technology for remote monitoring of patients with neurodegenerative diseases. Amir has 15+ years of experience in the healthcare industry, academic research, clinical data science, and Around the Pill solutions. He is currently the Head of R&D at Mitsubishi Tanabe Pharma Holding America, and a freelance consultant for several HealthTech companies in the DTx space. Formerly, Amir served as the Head of Digital Innovation at Pfizer’s Rare Disease Unit, where he led the development of technology solutions and mobile health apps, from proof-of-concept studies to global scale-up implementation in clinical trials. Prior to pharma, Amir was a professor of pediatrics at Harvard Medical School and a PI on multiple technology-driven clinical trials. Amir leads Redenlab’s digital health & strategy, driving innovation in new markets and disease groups.

Meet More of the team